- Home
- IGD vs TKNO Comparison
IGD vs TKNO Comparison
Compare IGD & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IGD
- TKNO
- Stock Information
- Founded
- IGD N/A
- TKNO 1996
- Country
- IGD United States
- TKNO United States
- Employees
- IGD N/A
- TKNO N/A
- Industry
- IGD Trusts Except Educational Religious and Charitable
- TKNO Medicinal Chemicals and Botanical Products
- Sector
- IGD Finance
- TKNO Health Care
- Exchange
- IGD Nasdaq
- TKNO Nasdaq
- Market Cap
- IGD 422.7M
- TKNO 356.4M
- IPO Year
- IGD N/A
- TKNO 2021
- Fundamental
- Price
- IGD $5.74
- TKNO $5.19
- Analyst Decision
- IGD
- TKNO Buy
- Analyst Count
- IGD 0
- TKNO 1
- Target Price
- IGD N/A
- TKNO $5.00
- AVG Volume (30 Days)
- IGD 215.3K
- TKNO 232.2K
- Earning Date
- IGD 01-01-0001
- TKNO 08-12-2025
- Dividend Yield
- IGD 9.15%
- TKNO N/A
- EPS Growth
- IGD N/A
- TKNO N/A
- EPS
- IGD N/A
- TKNO N/A
- Revenue
- IGD N/A
- TKNO $38,250,000.00
- Revenue This Year
- IGD N/A
- TKNO $8.73
- Revenue Next Year
- IGD N/A
- TKNO $16.53
- P/E Ratio
- IGD N/A
- TKNO N/A
- Revenue Growth
- IGD N/A
- TKNO 3.79
- 52 Week Low
- IGD $4.60
- TKNO $1.16
- 52 Week High
- IGD $5.26
- TKNO $10.37
- Technical
- Relative Strength Index (RSI)
- IGD 54.01
- TKNO 33.96
- Support Level
- IGD $5.64
- TKNO $5.15
- Resistance Level
- IGD $5.79
- TKNO $5.65
- Average True Range (ATR)
- IGD 0.05
- TKNO 0.34
- MACD
- IGD -0.00
- TKNO -0.04
- Stochastic Oscillator
- IGD 62.50
- TKNO 25.68
About IGD Voya Global Equity Dividend and Premium Opportunity Fund
Voya Global Equity Dividend and Premium Opportunity Fund are a United States-based diversified, closed-end Fund. The primary objective of the Fund is to seek to provide investors with a high level of income from a portfolio of common stocks with historically attractive dividend yields and premiums from call option writing. The secondary investment objective of the company is capital appreciation. Under normal market conditions, the Fund will invest at least 80% of its managed assets in a portfolio of common stocks of dividend-paying companies located throughout the world.
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.